Modern drugs for obesity and metabolic syndrome treatment (Review)

The article reviews modern anti-obesity drugs to identify new trends in effective and safe risk factors reduction (diabetes, cardiovascular and musculoskeletal diseases, cancer). Some anti-obesity drugs have a high risk of adverse effects on the CNS and cardiovascular system, so they should be used...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	M. L. Maximov, O. V. Dralova, V. G. Kukes, V. N. Chubarev, V. V. Tarasov
פורמט:	Artigo
שפה:	Russo
יצא לאור:	Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) 2016-12-01
סדרה:	Сеченовский вестник
נושאים:	modern pharmacotherapy of obesity tesofensine orlistat lorcaserin sibutramine rimonabant beloranib liraglutide qsymia adipokines
גישה מקוונת:	https://www.sechenovmedj.com/jour/article/view/575
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!